Free Trial

Craneware (LON:CRW) Stock Price Passes Above 200 Day Moving Average - Here's Why

Craneware logo with Medical background

Key Points

  • Craneware plc's stock price has surpassed its 200-day moving average, signaling a potential change in trading sentiment as it reached GBX 2,185 ($29.36) during trading.
  • Analysts maintain a positive outlook, with several firms issuing "buy" ratings and target prices ranging from GBX 2,650 to GBX 2,800, resulting in a consensus target price of GBX 2,725.
  • The company's current financial ratios include a debt-to-equity ratio of 12.22 and a market capitalization of approximately £754.98 million, indicating a potentially high leverage situation.
  • Interested in Craneware? Here are five stocks we like better.

Craneware plc (LON:CRW - Get Free Report)'s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,005.17 ($27.13) and traded as high as GBX 2,185 ($29.56). Craneware shares last traded at GBX 2,140 ($28.95), with a volume of 27,448 shares.

Analysts Set New Price Targets

A number of research firms have recently commented on CRW. Shore Capital reiterated a "buy" rating and issued a GBX 2,650 price objective on shares of Craneware in a research note on Wednesday, July 16th. Berenberg Bank began coverage on Craneware in a research note on Wednesday, July 16th. They issued a "buy" rating and a GBX 2,800 price objective on the stock. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of GBX 2,725.

Check Out Our Latest Report on Craneware

Craneware Stock Up 7.7%

The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The stock has a market capitalization of £819.74 million, a P/E ratio of 5,447.06 and a beta of 0.28. The firm has a 50 day moving average of GBX 2,268.01 and a 200-day moving average of GBX 2,007.73.

Craneware Company Profile

(Get Free Report)

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

Featured Articles

Should You Invest $1,000 in Craneware Right Now?

Before you consider Craneware, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.

While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.